Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Sean Marrache"'
Autor:
Peter Finnegan, Bruce Adams, Daniel Reyes, Sean Marrache, Payam Shahi, FuNien Tsai, Thomas Vollbrecht, Micheal Stubbington
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Michael JT Stubbington, Bruce Adams, Daniel Reyes, Ariel Royall, Maengseok Song, Sean Marrache, Payam Shahi, FuNien Tsai, Peter Finnegan, Thomas Vollbrecht, Tanmayee Khadilkar, David Jaffe, Ravi Ramenani, Wyatt McDonnell
Publikováno v:
The Journal of Immunology. 208:173.09-173.09
A more complete understanding of immune responses to disease requires consideration of multiple different cell types across both the innate and adaptive branches of the immune system along with the detection of many different analytes. We used Barcod
Autor:
Michael JT Stubbington, Bruce Adams, Daniel Reyes, Ariel Royall, Maengseok Song, Sean Marrache, Payam Shahi, FuNien Tsai, Peter Finnegan, Thomas Vollbrecht, Tanmayee Khadilkar, David Jaffee, Ravi Ramenani, Wyatt McDonnell
Publikováno v:
The Journal of Immunology. 208:116.09-116.09
Humans who have recovered from infectious disease possess a memory B cell pool that contains highly-potent antibodies against the cleared pathogenic agent. This pool is a valuable source of therapeutic antibodies but identifying these requires a meth
Autor:
Sau Wai Hung, Hardik Mody, Sean Marrache, Yangzom D Bhutia, Franklin Davis, Jong Hyun Cho, Jason Zastre, Shanta Dhar, Chung K Chu, Rajgopal Govindarajan
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71196 (2013)
We evaluated the potential of an investigational histone methylation reversal agent, 3-deazaneplanocin A (DZNep), in improving the chemosensitivity of pancreatic cancer to nucleoside analogs (i.e., gemcitabine). DZNep brought delayed but selective cy
Externí odkaz:
https://doaj.org/article/f4d6a8385eaa4032b590cec30340474a
Autor:
Anil Kumar, Shanta Dhar, Elizabeth W. Howerth, Sean Marrache, Bhabatosh Banik, Nagesh Kolishetti, Ru Wen
Atherosclerosis, the deadliest disease in the United States, arises due to the build up of plaques in the arteries as a result of excessive cholesterol deposition and an impaired cholesterol removal process. High density lipoproteins (HDL), popularly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150e3569ec930f73b168c05a735b2bc6
https://europepmc.org/articles/PMC5744677/
https://europepmc.org/articles/PMC5744677/
Autor:
Shanta Dhar, Sean Marrache
Publikováno v:
Chemical Science
Mitochondrial delivery of 3-bromopyruvate for metabolic reprogramming of cancer cells.
A key hallmark of many aggressive cancers is accelerated glucose metabolism. The enzymes that catalyze the first step of glucose metabolism are hexokinases. E
A key hallmark of many aggressive cancers is accelerated glucose metabolism. The enzymes that catalyze the first step of glucose metabolism are hexokinases. E
Publikováno v:
Proceedings of the National Academy of Sciences. 111:10444-10449
Chemoresistance of cisplatin therapy is related to extensive repair of cisplatin-modified DNA in the nucleus by the nucleotide excision repair (NER). Delivering cisplatin to the mitochondria to attack mitochondrial genome lacking NER machinery can le
Publikováno v:
ACS Chemical Biology
Tumor growth is fueled by the use of glycolysis, which normal cells use only in the scarcity of oxygen. Glycolysis makes tumor cells resistant to normal death processes. Targeting this unique tumor metabolism can provide an alternative strategy to se
Publikováno v:
Angewandte Chemie International Edition. 53:1963-1967
Cancer-associated inflammation induces tumor progression to the metastatic stage, thus indicating that a chemo-anti-inflammatory strategy is of interest for the management of aggressive cancers. The platinum(IV) prodrug Platin-A was designed to relea
Autor:
Shanta Dhar, Sean Marrache
Publikováno v:
Proceedings of the National Academy of Sciences. 109:16288-16293
Mitochondrial dysfunctions cause numerous human disorders. A platform technology based on biodegradable polymers for carrying bioactive molecules to the mitochondrial matrix could be of enormous potential benefit in treating mitochondrial diseases. H